Todd R. Palmby

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 336 citations

Metastatic Breast Cancer, Independent Review Committee, Breast Oncology +13

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas et al. · Clinical Cancer Research · 2013 · 240 citations

Hematological Malignancy, Thrombosis, Translational Medicine +15

An essential role for Rac1 in endothelial cell function and vascular development

Wenfu Tan, Todd R. Palmby, Julie Gavard et al. · The FASEB Journal · 2008 · 221 citations

Endothelial Cells, Tyrosine Kinase, Immunology +21

U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma

Michael D. Axelson, Ke Liu, Xiaoping Jiang et al. · Clinical Cancer Research · 2013 · 182 citations · Full text

Regulatory Considerations, U.s. Food, Medicine +12

Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation

Anurag Singh, Antoine E. Karnoub, Todd R. Palmby et al. · Oncogene · 2004 · 173 citations

Oncogenic Agent, Medicine, Cancer Cell Biology +7